OverviewChartNewsTraderScreen

BNP Paribas Discount Zert MRNA 27.../  DE000PN53VU9  /

Frankfurt Zert./BNP
6/14/2024  9:40:24 PM Chg.+0.330 Bid9:59:12 PM Ask9:59:12 PM Underlying Strike price Expiration date Option type
120.980EUR +0.27% 120.930
Bid Size: 200		 120.980
Ask Size: 200		 Moderna Inc - USD 6/27/2024 Call
GlobeNewswire 6/13 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire 6/5 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
TeleTrader 5/29 US opens lower, Dow Jones drops 300 points
GlobeNewswire 5/22 Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
TeleTrader 5/20 Dow slumps 195 points at closing bell after corporate news
TeleTrader 5/13 Wall Street closes mixed ahead of key inflation data
GlobeNewswire 5/12 TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire 5/8 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
TeleTrader 5/2 US surges at close as traders weigh Fed remarks
TeleTrader 5/2 Moderna surges 9% as Q1 revenue beat expectations
GlobeNewswire 5/2 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
TeleTrader 5/2 Moderna sees $167M in Q1 revenue, beats forecasts
TeleTrader 5/2 US higher premarket after Fed's decision
GlobeNewswire 5/1 Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
TeleTrader 4/24 Moderna, OpenAI partner on mRNA medicine advancement
TeleTrader 4/9 US markets close mostly higher ahead of inflation report
GlobeNewswire 4/4 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
TeleTrader 3/28 US closes mixed amid data
TeleTrader 3/26 Wall Street closes lower after economic data
GlobeNewswire 3/21 Immatics Announces Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 3/11 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire 3/4 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire 2/29 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2/27 CytomX Therapeutics to Present at Upcoming March Investor Conferences